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Conclusion: Monitoring of intragraft glucose and its metabolites concentra-
tions is a powerful method for IGF assessment and vascular complications
diagnosis early after LT. For the development of accurate microdialysis-based
IGF criteria more cases are needed.
BOS028 THE SYNTHESIS OF COAGULATION FACTORS DURING
NORMOTHERMIC MACHINE PERFUSION OF LIVERS IS
IMPAIRED BY ISCHEMIA IN PIGS AND MIGHT PREDICT
GRAFT VIABILITY
Nicholas Gilbo, Marc Jacquemin, Silvia Lazzaro, Tine Wylin, Veerle Heedfeld,
Jacques Pirenne, Ina Jochmans, Diethard Monbaliu
KU Leuven
Background: Normothemic Machine Perfusion (NMP) allows liver viability
assessment. Coagulation Factors (F) are synthetized by the liver and are
candidate markers of function of hepatocytes (FV, FVII, FIX, FX) and sinusoidal
endothelial cells (FVIII). We investigated if coagulation factors discriminate
functioning and injured livers during NMP.
Methods: Porcine livers underwent 6 h NMP after no (WI0, n = 5) or 60 min
Warm Ischemia (WI60, n = 5). FV, FVII, FVIII, FIX, FX, aspartate transferase
(AST), bile production lactate (Lac), Hyaluronic Acid (HAc), Vena Portae (VP)
and Hepatic Artery (HA) resistance were measured during NMP. The synthesis
of coagulation factors was investigated within-groups with repeated measures
ANOVA, between-groups with Student’s T test, and correlated with markers of
injury/function of hepatocytes (AST, bile production, Lac) and sinusoidal
endothelial cells (HAc, VP, and HA resistance) with Kendall-tau.
Results: Coagulation factors concentration increased during NMP in both
groups (p < 0.05); however, WI60 synthetized less factors thanWI0 (p < 0.05).
FV, FVII, FIX, and FX correlated inversely with AST (p < 0.0001), positively
with bile production (p < 0.05), and negatively with Lac (p ≤ 0.0001). FVIII was
inversely correlated with HAc (p = 0.008), VP (p = 0.002) and HA resistance
(p = 0.13). Notably, FV and FVIII discriminated functioning and injured grafts
within 1 h NMP. Grafts producing the highest amount of FV at 1 h NMP
released the lowest quantity of AST (s:-0.93, p = 0.001) and had the lowest Lac
concentration (s:-0.51; p = 0.04). Similarly, livers producing the highest amount
of FVIII at 1 h released the least quantity of HAc (s:-0.58, p = 0.02).
Conclusions: The synthesis of coagulation factors during NMP is reduced by
ischemic injuries in pigs. Coagulation factors are promising markers of function
of hepatocytes and sinusoidal cells discriminating between functioning and
injured grafts early during NMP and should be further investigated in human
studies.
BOS029 ASINGLE CENTER EXPERIENCEWITH 157 CONTROLED
DCD-LIVER TRANSPLANTATIONS
Astrid Schielke, Maite Paolucci, Nicolas Meurisse, Morgan Vandermeulen,
Anne Lamproye, Jean Delwaide, Jean Joris, Abdour Kaba, Pierre Honore,
Olivier Detry
CHU Li!ege
Introduction: Donation after circulatory death (DCD) have been proposed to
partially overcome the organ donor shortage. DCD-LT remains controversial,
with reported increased risk of graft loss and retransplantation. The authors
retrospectively reviewed a single centre experience with controlled DCD-LT in
a 15-year period.
Patients and Methods: 157 DCD-LT were consecutively performed between
2003 and 2017. All donation and procurement procedures were performed as
controlled DCD in the operating theatre. Data are presented as median
(ranges). Median donor age was 57 years (16–83). Median DRI was 2.242
(1.322–3.554). Allocation was centre-based. Median recipient MELD score at
LT was 15 (6–40). Mean follow-up was 37 months. No patient was lost to
follow-up.
Results: Median total DCD warm ischemia was 19 min (7–39). Median total
ischemia was 313 min (181–586). Patient survivals were 89.8%, 75.5% and
73.1% at 1,3 and 5 years, respectively. Graft survivals were 89%, 73.8% and
69.8% at 1,3 and 5 years, respectively. Biliary complications included mainly
anastomotic strictures, that were managed either by endoscopy or hepatico-
jejunostomy. Two patients were retransplanted due to intrahepatic ischemic
lesions.
Conclusion: In this series, DCD LT provides results similar to classical LT.
Short cold ischemia and recipient selection with low MELD score may be the
keys to good results in DCD LT, in terms of graft survival and avoidance of
ischemic cholangiopathy.
BOS030 EXPANDING CRITERIA FOR EARLY LIVER
TRANSPLANTATION IN SEVERE ALCOHOLIC
HEPATITIS
Debora Angrisani, Panariello Adelaide, Chiara Mazzarelli, Paola Prandoni,
Raffaella Vigano’, Giovanni Perricone, Stella De Nicola, Marcello Vangeli, Aldo
Airoldi, Rosa Stigliano, Anna Mariani, Mauro Percudani, Luciano De Carlis,
Saverio Belli Luca
Niguarda Hospital
Background: In 2011 Mathurin et al showed that early liver transplant(eLT)
dramatically improves survival in highly selected patients with severe alcoholic
hepatitis(SAH). Recently, a real life US multicenter study demonstrated that
eLT can be successfully performed also in patients fulfilling less stringent
selection criteria. Where the limits of expanded criteria should be set and how
much the percentage of patients with SAH eligible for LT could be increased is
unknown.
Methods: In January 2016 a program of eLT for SAH was started at the
Niguarda Hospital of Milan. Corticosteroids(CS) were not used in case of
infection, malnutrition or bleeding. A dedicated team performed an accurate
psycho-social evaluation and monitoring pre and post-LT.
Results: Twenty-eight consecutive cirrhotic patients at first episode of SAH
were identified. Twelve patients with median baseline Maddrey score(MS) 73
and MELD-Na 26(43%) improved with or without CS. MELD-Na decreased to
19 after 1 month. None died after a median follow up of 13(1–32) months. The
remaining 16 patients(57%) were evaluated for eLT. Seven patients with
median baseline MS 91 and MELD-Na 33 were excluded from eLT: 2 for
uncontrolled psychiatric disease, 1 due to cardiologic contraindication and 4
because ‘too sick for transplant’. All but 1 died. Finally, 9 patients underwent LT,
3 after unsuccessful CS therapy(median Lille score 0.9). Their median MF and
MELD-Na at admission were 104 and 32 respectively. Median time between
admission and listing was 19 days; LT occurred on average days 8 after listing
in all but 1 case who waited 94 days. Median MELD-Na at LT was 30. All
patients undergoing LT are alive after a median follow up of 16(3–29) months.
To date none relapsed alcohol use.
Conclusions: eLT was feasible and effective in almost 50% patients with
SAH not responding to medical therapy, with a 1-year survival of 100%.Strin-
gent psycho-logical support pre and post LT was crucial to avoid alcohol
recidivism.
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